ERBB2 and triple-negative breast carcinoma: We have generated genome-wide transcriptional profiles of blood samples from 14 patients with triple-negative breast cancer (TNBC/ER−PR−HER2−), 15 patients with hormone-dependent breast cancer (ER+PR+HER2−), and seven healthy donors (CTR).